Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Metformin Glycinate on Metabolic Control and Inflammatory Mediators in Type 2 Diabetes (COMET)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2014 by Laboratorios Silanes S.A. de C.V..
Recruitment status was:  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Laboratorios Silanes S.A. de C.V.
ClinicalTrials.gov Identifier:
NCT01386671
First received: June 29, 2011
Last updated: February 19, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2016
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)
Publications: